Fat isn’t just something we eat: it may lie at the heart of a new approach to treating cancer.
Cells create their own fat molecules to build critical cellular structures. Reuben Shaw’s lab, along with academic and industry collaborators, has found a way to obstruct this instrumental process to stifle cancer’s growth, detailed September 2016 in Nature Medicine. Like halting the delivery of supplies to a construction site, the approach stalls the molecular building blocks cancer needs to grow.
Researchers had previously hypothesized that interrupting cells’; lipid assembly line could disable cancer, but it was only recently that they were able to disrupt the process and test this theory. Shaw, first author Robert Svensson, and colleagues partnered with Nimbus Therapeutics to test a molecule that shuts off a critical player in lipid synthesis, an enzyme called Acetyl-CoA Carboxylase, or ACC.
In large-scale tests in animal models of cancer and in transplanted human lung cancer cells, the novel ACC inhibitor led to tumor masses shrinking by roughly two-thirds compared to untreated animals. And when the team paired this new drug with one of the common treatments for non-small lung cancer (carboplatin), the anti-tumor response was even greater: a dramatic 87 percent of tumors were suppressed, compared to 50 percent with the standard treatment alone, pointing to a promising drug candidate for lung cancer as well as liver and other types of cancer.Read News Release
- The Jacobs EffectThe Salk Institute and those helped by the Institute’s biomedical research have been particularly fortunate that Jacobs served as chairman of Salk’s Board for 10 years and that he and his wife have supported Salk science for even longer.
- Sparks of InnovationProviding bright and original minds the opportunity to quickly pursue a new idea does frequently result in unexpected and occasionally fundamental breakthroughs, substantially supporting progress in solving our most pressing science and medical problems.
- Unraveling the Mysteries of LifeStaff Scientist Abby Buchwalter is studying a part of the nucleus called the nuclear lamina. Akin to a skeleton, the nuclear lamina provides structural support and helps organize the nucleus, the command center of cells.